JP2021520340A5 - - Google Patents
Info
- Publication number
- JP2021520340A5 JP2021520340A5 JP2020552732A JP2020552732A JP2021520340A5 JP 2021520340 A5 JP2021520340 A5 JP 2021520340A5 JP 2020552732 A JP2020552732 A JP 2020552732A JP 2020552732 A JP2020552732 A JP 2020552732A JP 2021520340 A5 JP2021520340 A5 JP 2021520340A5
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- triazole
- acetamide
- methyl
- fluorophenyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1805527.7 | 2018-04-04 | ||
| GBGB1805527.7A GB201805527D0 (en) | 2018-04-04 | 2018-04-04 | Compounds and their use as pde4 activators |
| PCT/GB2019/050976 WO2019193342A1 (en) | 2018-04-04 | 2019-04-04 | Compounds and their use as pde4 activators |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021520340A JP2021520340A (ja) | 2021-08-19 |
| JP2021520340A5 true JP2021520340A5 (https=) | 2022-03-15 |
| JPWO2019193342A5 JPWO2019193342A5 (https=) | 2022-03-15 |
| JP7330202B2 JP7330202B2 (ja) | 2023-08-21 |
Family
ID=62142313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552732A Active JP7330202B2 (ja) | 2018-04-04 | 2019-04-04 | 化合物およびｐｄｅ４活性剤としてのそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11560373B2 (https=) |
| EP (1) | EP3774780B1 (https=) |
| JP (1) | JP7330202B2 (https=) |
| GB (1) | GB201805527D0 (https=) |
| WO (1) | WO2019193342A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112194620B (zh) * | 2020-12-04 | 2021-02-26 | 苏州开元民生科技股份有限公司 | 一种2-乙基-4-氰基吡啶的制备方法 |
| GB202102088D0 (en) | 2021-02-15 | 2021-03-31 | Mironid Ltd | Compounds and their use as pde4 activators |
| JP2024511204A (ja) | 2021-03-23 | 2024-03-12 | バイオエイジ ラブス， インコーポレイテッド | Ｎｌｒｐ３インフラマソームの阻害剤 |
| CN119053602A (zh) | 2022-01-28 | 2024-11-29 | 柏奥艾奇实验室公司 | Nlrp3炎性体的n-氧化物抑制剂 |
| GB202212000D0 (en) | 2022-08-17 | 2022-09-28 | Mironid Ltd | Compounds and their use as PDE4 activators |
| GB202211999D0 (en) | 2022-08-17 | 2022-09-28 | Mironid Ltd | Compounds and their use as PDE4 activators |
| IT202200024948A1 (it) * | 2022-12-05 | 2024-06-05 | Angelini Pharma S P A | Composti attivatori dei canali potassio KV7.2/KV7.3 |
| US12509459B2 (en) | 2024-03-26 | 2025-12-30 | BioAge Labs, Inc. | Inhibitors of NLRP3 inflammasome |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ178996A (en) | 1974-11-15 | 1978-06-02 | Kornis G | Pyrfazole amides and thioamides;herbicidal compositions |
| JP3890453B2 (ja) | 1996-09-18 | 2007-03-07 | リードケミカル株式会社 | 新規２，４−ジオキソピロリジンおよび２，４−ジオキソテトラヒドロフラン誘導体及び該化合物を有効成分とする医薬 |
| JP2006518738A (ja) | 2003-02-12 | 2006-08-17 | トランス テック ファーマ，インコーポレイテッド | 治療薬としての置換アゾール誘導体 |
| AU2004232973A1 (en) | 2003-04-18 | 2004-11-04 | Memory Pharmaceuticals Corporation | Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| US7056932B2 (en) | 2003-12-19 | 2006-06-06 | Hoffman-La Roche Inc. | Heterocyclyl substituted 1-alkoxy acetic acid amides |
| US7726930B2 (en) | 2005-05-16 | 2010-06-01 | Swaploader U.S.A., Ltd. | Adjustable height jib for a hook-lift hoist |
| US20070191711A1 (en) | 2006-02-15 | 2007-08-16 | Misonix, Incorporated | Liquid processing and handling apparatus and associated method for use in medical procedures |
| EP2013176A2 (en) | 2006-02-27 | 2009-01-14 | Sterix Limited | Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer |
| EP2057152A1 (de) | 2006-08-07 | 2009-05-13 | Boehringer Ingelheim International GmbH | Enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| WO2009131956A1 (en) | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising triazole derivatives |
| US20100144733A1 (en) | 2008-04-28 | 2010-06-10 | Institute For Oneworld Health | Compounds, compositions and methods comprising heteroaromatic derivatives |
| WO2010059838A2 (en) | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects |
| DE102009013642A1 (de) | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylalaninderivate und deren Verwendung |
| US8343976B2 (en) | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
| ES2707598T3 (es) | 2009-05-12 | 2019-04-04 | Koninklijke Philips Nv | Fosfodiesterasa 4D7 como marcador para cáncer maligno de próstata sensible a hormonas |
| ES2700877T3 (es) | 2009-05-12 | 2019-02-19 | Koninklijke Philips Nv | Fosfodiesterasa 4D7 como marcador de cáncer de próstata |
| MX341050B (es) | 2010-04-07 | 2016-08-05 | Celgene Corp * | Metodos para tratar infeccion viral respiratoria. |
| EP2742030B1 (de) | 2011-08-11 | 2016-07-27 | Bayer Intellectual Property GmbH | 1,2,4-triazolyl-substituierte ketoenole zum einsatz im pflanzenschutz |
| US8642774B2 (en) | 2011-12-08 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Compounds |
| US8889677B2 (en) | 2012-01-17 | 2014-11-18 | Boehringer Ingellheim International GmbH | Substituted triazoles useful as mGlu5 receptor modulators |
| CN105228616B (zh) | 2013-03-15 | 2019-05-03 | 实发生物医学公司 | 抗前蛋白转化酶枯草杆菌蛋白酶Kexin 9型（抗PCSK9）化合物及其用于治疗和/或预防心血管疾病的方法 |
| US20170087129A1 (en) | 2014-05-16 | 2017-03-30 | Celgene Corporation | Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators |
| GB201504763D0 (en) | 2015-03-20 | 2015-05-06 | Mironid Ltd | Compounds and uses |
| WO2017044828A1 (en) | 2015-09-11 | 2017-03-16 | VenatoRx Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
| GB201616439D0 (en) | 2016-09-28 | 2016-11-09 | Mironid Limited | Compounds and uses |
-
2018
- 2018-04-04 GB GBGB1805527.7A patent/GB201805527D0/en not_active Ceased
-
2019
- 2019-04-04 JP JP2020552732A patent/JP7330202B2/ja active Active
- 2019-04-04 WO PCT/GB2019/050976 patent/WO2019193342A1/en not_active Ceased
- 2019-04-04 US US17/044,007 patent/US11560373B2/en active Active
- 2019-04-04 EP EP19717570.6A patent/EP3774780B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520340A5 (https=) | ||
| Asahina et al. | Discovery of BMS-986235/LAR-1219: a potent formyl peptide receptor 2 (FPR2) selective agonist for the prevention of heart failure | |
| JP2005519958A5 (https=) | ||
| JP3712393B2 (ja) | 含窒素芳香環誘導体 | |
| EP0914319B1 (en) | Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists | |
| TWI353983B (en) | Aromatic compound and pharmaceutical composition c | |
| CA2478183A1 (en) | Substituted amides | |
| JP5600754B2 (ja) | ピラジン誘導体および神経障害の処置におけるそれらの使用 | |
| KR20080032188A (ko) | 히스톤 탈아세틸화 효소 억제제 | |
| TWI598325B (zh) | 苯甲醯胺類 | |
| JP2006509748A5 (https=) | ||
| JP2019532929A5 (https=) | ||
| JP2007519754A5 (https=) | ||
| HRP20040823A2 (en) | Substituted amides active at the cannabinoid-1 receptor | |
| US8946430B2 (en) | Quinolinone carboxamide inhibitors of endothelial lipase | |
| TW200523253A (en) | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | |
| US7915424B2 (en) | Pyridyl derivatives and their use as mGlu5 antagonists | |
| CN102686572A (zh) | 用于治疗cns病的噁唑啉衍生物 | |
| US11046683B2 (en) | Activator of TREK (TWIK RElated K+ channels) channels | |
| JP2014520860A (ja) | タンキラーゼ阻害剤として使用するための４−オキソ−３，５，７，８−テトラヒドロ−４Ｈ−ピラノ｛４，３−ｄ｝ピルミニジニル化合物 | |
| CN112334450A (zh) | 作为RORγt的调节剂的苯基和吡啶基取代的咪唑 | |
| CN101160125A (zh) | 烟酸受体激动剂、含有这样化合物的组合物和治疗方法 | |
| JP2020502058A5 (https=) | ||
| US20080167371A1 (en) | Diaryl, Dipyridinyl and Aryl-Pyridinyl Derivatives and Uses Thereof | |
| CN112292373A (zh) | 作为RORγt的调节剂的吡啶基吡唑类 |